21 hours ago
1
alexsl
Novo Nordisk (NVO) was downgraded to Hold from Buy at HSBC following the company’s recent warning that its 2025 exit growth rate will likely settle into mid-single digits.
This adjustment reflects mounting concerns over the company’s growth trajectory and structural
© FBT Company 2025. All rights are reserved
English (US) ·